FDCDDQ
BLCM

Federation des caisses Desjardins du Quebec’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-260
Closed -$30K – 2194
2017
Q3 		$30K Buy
260
+140
+117% +$14.7K ﹤0.01% 1443
2017
Q2 		$14K Buy
+120
New +$14.9K ﹤0.01% 1653

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BLCM Position: Q4 2017 in Review

Federation des caisses Desjardins du Quebec sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2017, closing a stake of 260 shares — an estimated $30K sold.

Federation des caisses Desjardins du Quebec first reported a position in BLCM in Q2 2017 and held it in 2 quarters. The position peaked at $30K in Q3 2017. 91 funds tracked by Wall St. Rank hold BLCM as of Q4 2017.

  • Federation des caisses Desjardins du Quebec reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 260 Bellicum Pharmaceuticals, Inc. shares in Q4 2017, an estimated $30K.
  • Federation des caisses Desjardins du Quebec first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2017 and held it in 2 quarters.
  • Federation des caisses Desjardins du Quebec's Bellicum Pharmaceuticals, Inc. position peaked at $30K in Q3 2017.
  • 91 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2017.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2017, filed 30 Aug 2024.